Sloan, Emily A.
Sampognaro, Paul J.
Junn, Jacqueline C.
Chin, Cynthia
Jacques, Line
Ramachandran, Prashanth S.
DeRisi, Joseph L.
Wilson, Michael R.
Kriegstein, Arnold R.
Bollen, Andrew W.
Solomon, David A.
Margeta, Marta http://orcid.org/0000-0001-6889-2488
Engstrom, John W.
Funding for this research was provided by:
American Academy of Neurology (P0534134)
William K. Bowes, Jr. Foundation
Sandler Foundation
National Institute of Neurological Disorders and Stroke (K08NS096117)
Article History
Received: 16 October 2019
Accepted: 22 October 2019
First Online: 28 October 2019
Compliance with ethical standards
:
: ARK is a co-founder and member of the board of Neurona Therapeutics. Other authors have no conflicts of interest relevant to this article.
: Informed consent was obtained from the individual participant described in the study.